Understand the source comparison
Comparison: NAD+ Protocols by Age Decade
30–40 Mild NAMPT decline 250mg NMN daily OR 150mg NR daily Optional. Resveratrol 250mg for SIRT1 support 18–25% Younger individuals can restore NAD+ with single-precursor dosing and minimal co-factor support. The salvage pathway is still efficient 40–50 NAMPT
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- 30–40
- Mild NAMPT decline
- 250mg NMN daily OR 150mg NR daily
- Optional. Resveratrol 250mg for SIRT1 support
- 18–25%
- Younger individuals can restore NAD+ with single-precursor dosing and minimal co-factor support. The salvage pathway is still efficient
- 40–50
- NAMPT decline + early mitochondrial dysfunction
- 300–400mg NMN + 150mg NR daily
- Quercetin 500mg, magnesium 400mg
- 25–32%
- This decade marks the shift toward dual-precursor protocols. CD38 inhibition with quercetin becomes measurably beneficial
- 50–60
- Severe NAMPT decline + elevated CD38 + inflammation
- 400–500mg NMN + 200–300mg NR daily
- Quercetin 500mg, resveratrol 500mg, methylated B-complex
- 30–38%
- The enzymatic bottlenecks require aggressive co-factor support and dual-precursor dosing. Single-precursor protocols underperform significantly
- 60+
- All above + mitochondrial membrane degradation
- 500mg NMN + 300mg NR + possible NAD+ IV therapy
- Quercetin 500mg, pterostilbene 150mg, PQQ 20mg, CoQ10 200mg
- 28–35% (supplementation alone)
- At this stage, oral supplementation alone may not suffice. Some patients benefit from periodic NAD+ IV infusions to bypass absorption barriers